Researchers Identify Traits Linked to Glp-1 Drug Response
Source: Getty Images Key Points: GLP-1 weight-loss drugs – Patient traits like muscle stiffness or osteoarthritis influence response. Response varies by drug – 12.5% super responders, 35% moderate, 47% minimal; newer drugs show better outcomes. Personalized treatment next – AI algorithms may help match patients to the most effective medication. U.S. researchers have identified clinical patterns that may help determine which patients respond best to GLP-1 weight-loss drugs such as Wegovy and Zepbound, according to findings published online ahead of peer review on Nov. 19. The analysis suggests that patient health characteristics before treatment may guide physicians in selecting the most effective medication. Early Response Patterns The research team, led by Venky Soundararajan of the Massachusetts-based data company conference, reviewed 14 million doctors’ notes and 15 million clinical entries from more than 135,000 patients. Each patient had taken only one GLP-1 weight-loss drugs. The...